Clominorex
Tools
Actions
General
Print/export
Print/export
In other projects
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DePiep (talk | contribs) at 15:45, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C9H9ClN2O |
Molar mass | 196.63 g/mol g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
References
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Clominorex" – news · newspapers · books · scholar · JSTOR (September 2009) (Learn how and when to remove this message) |
- ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |